In a premenopausal woman with abnormal uterine bleeding who is not using any form of contraception, what is the appropriate diagnostic work‑up and management?

Diagnostic Work-Up and Management of Abnormal Uterine Bleeding in Premenopausal Women Not Using Contraception

Begin with transvaginal ultrasound (TVUS) combined with transabdominal ultrasound as the first-line imaging modality to identify structural causes of abnormal uterine bleeding, while recognizing that endometrial thickness measurements have no validated diagnostic value in premenopausal women. 1

Initial Diagnostic Approach

Essential Laboratory Testing

• Pregnancy test (beta-hCG) is mandatory in all premenopausal women with abnormal uterine bleeding 1, 2
• Complete blood count with platelets to assess for anemia and thrombocytopenia 3, 2
• Thyroid-stimulating hormone (TSH) and prolactin levels when ovulatory dysfunction is suspected 1
• Coagulation studies if bleeding history suggests underlying coagulopathy 2

Physical Examination Priorities

• Speculum examination to exclude cervical and vaginal sources of bleeding 4
• Bimanual pelvic examination to assess uterine size and adnexal masses 3
• Look specifically for signs of hyperandrogenism, thyroid disease, or systemic bleeding disorders 1

Imaging Strategy

First-Line: Transvaginal Ultrasound

TVUS combined with transabdominal ultrasound provides comprehensive pelvic assessment with high sensitivity for structural abnormalities including polyps, adenomyosis, and leiomyomas. 1

Critical caveat: In premenopausal women, endometrial thickness has NO validated upper limit cutoff and is NOT an indicator of endometrial pathology—even thickness <5mm can harbor polyps or other pathology. 1 This contrasts sharply with postmenopausal women where ≥5mm thickness prompts endometrial sampling 1

• TVUS demonstrates 82.5% sensitivity and 84.6% specificity for adenomyosis 1
• Abnormal echogenicity and texture of the endometrium correlates with significant pathology regardless of thickness 1
• Color Doppler should be included to identify vascular pedicles in endometrial polyps (specificity 62-98%) 1

Second-Line: Saline Infusion Sonohysterography

If TVUS demonstrates focal endometrial abnormality or findings are inconclusive, proceed to saline infusion sonohysterography. 1

• Achieves 96-100% sensitivity and 94-100% negative predictive value for intrauterine pathology 1
• Superior to TVUS alone for characterizing endometrial polyps and assessing myometrial involvement of leiomyomas 1
• Use sterile saline (not gel) as the standard contrast agent 1

Third-Line: MRI Pelvis

Reserve MRI for cases where ultrasound incompletely visualizes the uterus or findings remain indeterminate. 1

• MRI identifies endometrial cancer with 79% sensitivity and 89% specificity 1
• Include diffusion-weighted sequences to differentiate benign from malignant pathology (area under curve 0.89) 1
• Use gadolinium-based IV contrast when performing MRI 1
• MRI achieves 78% sensitivity and 93% specificity for adenomyosis 1

Endometrial Sampling Indications

Perform endometrial biopsy in premenopausal women with AUB if ANY of the following risk factors are present: 2

• Age >45 years (mandatory regardless of other factors) 2
• Age ≤45 years with:
  • Obesity
  • Polycystic ovary syndrome or chronic anovulation
  • Diabetes mellitus
  • Family history of endometrial or colon cancer
  • Failed medical management 2

Endometrial biopsy is preferred over dilation and curettage due to lower invasiveness, greater safety, and reduced cost 1

When Biopsy May Be Insufficient

• Focal lesions (polyps, submucous leiomyomas) may be missed by blind sampling 1
• Proceed to hysteroscopy if medical treatment fails or when biopsy results don't explain symptoms 1
• Hysteroscopy allows direct visualization of the endometrial cavity and endocervix 1

Management Algorithm

Medical Management (First-Line)

Efficacy ranking for idiopathic AUB: 5

1. Levonorgestrel intrauterine device (most effective) 5
2. Tranexamic acid (when hormones contraindicated or immediate pregnancy desired) 5
3. Combined oral contraceptives 1
4. Oral progestogens (21 days per month) 5
5. NSAIDs 5

• Iron supplementation is mandatory for patients with iron-deficiency anemia 5
• Treatment goals include stopping acute bleeding, preventing heavy bleeding episodes, and addressing quality of life 1

Surgical Management (Second-Line)

Reserve surgical intervention for failed medical management, contraindications to medical therapy, or significant structural lesions. 1

Conservative surgical options (in order of preference): 5

1. Second-generation endometrial ablation (thermal balloon, microwave, radiofrequency)
2. First-generation techniques (endometrectomy, roller-ball) if second-generation unavailable
3. Hysteroscopic polypectomy or myomectomy for focal lesions 4

Hysterectomy should NOT be first-line for functional bleeding but may be necessary when conservative measures fail 5. If performed, use vaginal or laparoscopic routes 5.

Common Pitfalls to Avoid

• Do not rely on endometrial thickness measurements in premenopausal women to exclude pathology 1
• Do not perform CT pelvis for AUB evaluation—no evidence supports its use 1
• Do not skip pregnancy testing regardless of patient's reported contraceptive practices 1, 2
• Do not use transvaginal ultrasound in virgins—transabdominal imaging is appropriate despite lower sensitivity 1
• Recognize that adenomyosis detection by TVUS drops dramatically (sensitivity 33.3%) when coexisting leiomyomas are present 1